136 related articles for article (PubMed ID: 9187839)
1. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; van Dyk U; Stoehr A; Albrecht H; Stellbrink HJ; Berger J; Meigel W
Dermatology; 1997; 194(3):234-7. PubMed ID: 9187839
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
3. Effects on pulmonary function of two regimens of chemotherapy for AIDS related Kaposi's sarcoma.
Denton AS; Simpson JK; Hallam M; Spittle MF; Miller RF
Clin Oncol (R Coll Radiol); 1996; 8(1):48-50. PubMed ID: 8688362
[TBL] [Abstract][Full Text] [Related]
4. Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
Zhong DT; Shi CM; Chen Q; Huang JZ; Liang JG; Lin D
J Cancer Res Clin Oncol; 2012 Mar; 138(3):425-30. PubMed ID: 22160130
[TBL] [Abstract][Full Text] [Related]
5. Low-dose multidrug chemotherapy plus Pneumocystis carinii pneumonia prophylaxis for HIV-related Kaposi's sarcoma.
Shields PG; Dawkins F; Holmlund J; Cohen P; Schulof RS
J Acquir Immune Defic Syndr (1988); 1990; 3(7):695-700. PubMed ID: 1693677
[TBL] [Abstract][Full Text] [Related]
6. [Kaposi's sarcoma].
Imamura A
Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma.
Tavio M; Vaccher E; Antinori A; Ammassari A; Cusini M; Fasan M; Accurso V; Garavelli LP; Repetto L; Tirelli U
Cancer; 1996 May; 77(10):2117-22. PubMed ID: 8640679
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine.
Gill P; Rarick M; Bernstein-Singer M; Harb M; Espina BM; Shaw V; Levine A
Am J Clin Oncol; 1990 Aug; 13(4):315-9. PubMed ID: 1696066
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
[TBL] [Abstract][Full Text] [Related]
11. Kaposi sarcoma in South African children.
Stefan DC; Stones DK; Wainwright L; Newton R
Pediatr Blood Cancer; 2011 Mar; 56(3):392-6. PubMed ID: 21225916
[TBL] [Abstract][Full Text] [Related]
12. Treatment of classical type Kaposi's sarcoma with paclitaxel.
Chao SC; Lee JY; Tsao CJ
Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
Chagaluka G; Stanley C; Banda K; Depani S; Nijram'madzi J; Katangwe T; Israels T; Bailey S; Mukaka M; Molyneux E
Eur J Cancer; 2014 May; 50(8):1472-81. PubMed ID: 24636877
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
[TBL] [Abstract][Full Text] [Related]
15. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.
Laubenstein LJ; Krigel RL; Odajnyk CM; Hymes KB; Friedman-Kien A; Wernz JC; Muggia FM
J Clin Oncol; 1984 Oct; 2(10):1115-20. PubMed ID: 6208343
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy.
Gill PS; Akil B; Colletti P; Rarick M; Loureiro C; Bernstein-Singer M; Krailo M; Levine AM
Am J Med; 1989 Jul; 87(1):57-61. PubMed ID: 2472743
[TBL] [Abstract][Full Text] [Related]
17. Opportunistic infections in Vancouver.
Marco M
GMHC Treat Issues; 1996 Sep; 10(9):4-6. PubMed ID: 11363841
[TBL] [Abstract][Full Text] [Related]
18. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
Hladunewich M; Sawka C; Fam A; Franssen E
J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
20. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]